Literature DB >> 26070447

The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults.

Philna Eksteen1, Marlien Pieters2, Zelda de Lange3, Herculina S Kruger4.   

Abstract

INTRODUCTION: Preliminary evidence indicates that the association of fibrinolytic potential, measured as clot lysis time (CLT), with body composition may differ from that of plasminogen activator inhibitor type-1 (PAI-1). We therefore investigated the association between fibrinolytic markers (plasminogen activator inhibitor type-1 activity (PAI-1act) and CLT) and body composition using detailed body composition analyses.
MATERIALS AND METHODS: Data from 1288 Africans were cross-sectionally analyzed. Body composition analysis included BMI, waist circumference (WC); waist to height ratio (WHtR), skinfolds and body fat percentage measured with air-displacement plethysmography and bioelectrical impedance analysis.
RESULTS: PAI-1act and CLT were significantly higher in women than in men, despite adjustment for differences in body composition. PAI-1act and CLT showed similar linear positive relationships with body composition (BMI, WC, WHtR, skinfolds) in men. In women CLT also showed a linear relationship with body composition, while PAI-1act levels plateaued at higher BMI and did not differ across skinfold categories. PAI-1act showed stronger correlations with body composition markers in men than it did in women, while no sex differences existed for CLT. PAI-1act associated more strongly with central obesity, while CLT associated with total body fat.
CONCLUSIONS: Observed differences may be related to differences in adipose tissue type, distribution and sequence of accumulation between sexes. PAI-1act is strongly influenced by accumulation of visceral adipose tissue, whereas CLT is associated with obesity independent of type and sequence of body fat accumulation in this African adult study population.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body composition; Clot lysis time; Fibrinolysis; PAI-1

Mesh:

Substances:

Year:  2015        PMID: 26070447     DOI: 10.1016/j.thromres.2015.05.033

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Plasminogen activator inhibitor-1 is associated with leukocyte telomere length in American Indians: findings from the Strong Heart Family Study.

Authors:  H Peng; F Yeh; J Lin; L G Best; S A Cole; E T Lee; B V Howard; J Zhao
Journal:  J Thromb Haemost       Date:  2017-05-03       Impact factor: 5.824

2.  Relationship between plasma plasminogen activator inhibitor-1 and hypertension in American Indians: findings from the Strong Heart Study.

Authors:  Hao Peng; Fawn Yeh; Giovanni de Simone; Lyle G Best; Elisa T Lee; Barbara V Howard; Jinying Zhao
Journal:  J Hypertens       Date:  2017-09       Impact factor: 4.844

Review 3.  A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease.

Authors:  Gael B Morrow; Claire S Whyte; Nicola J Mutch
Journal:  Front Cardiovasc Med       Date:  2021-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.